Aurobindo Pharma Limited (NSE:AUROPHARMA)
India
· Delayed Price · Currency is INR 1,191.70
+3.50 (0.29%)
May 23, 2025, 3:30 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 695.28 billion as of May 23, 2025. Its market cap has increased by 2.01% in one year.
Market Cap
695.28B
Enterprise Value
710.93B
Revenue
309.22B
Ranking
n/a
PE Ratio
20.01
Stock Price
1,191.70
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 695.28B, an increase of 7,140.01%. That is a compound annual growth rate of 20.55%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,039.52B |
| Divi's Laboratories | 1,721.03B |
| Cipla | 1,198.70B |
| Apollo Hospitals Enterprise | 1,015.77B |
| Mankind Pharma | 1,003.78B |
| Zydus Lifesciences | 914.26B |
| Alkem Laboratories | 632.26B |
| Fortis Healthcare | 542.85B |